Clinical Trial Update: Safety and Efficacy of γδ T Cell Against Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports safety and efficacy data for γδ T cell therapy targeting gastric cancer in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• T-cell therapy

Snippet

Sponsor: Beijing Doing Biomedical Co., Ltd. | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN